HEALTHWSOC ABC CHARLOTTE
Recall alert: Thyroid medication Levothyroxine recalled nationwide
The FDA has classified a nationwide recall of Levothyroxine, a thyroid medication, as a Class II recall due to being 'subpotent.' Major Pharmaceuticals, based in Dublin, Ohio, issued the voluntary recall on July 13, with the FDA officially marking it Class II on July 17.
Mentioned
Related Signal
Adjacent reporting
- Recall alert: Cetirizine Hydrochloride recalled over cross-contamination
- Recall alert: 2.5M bottles of eye drops recalled for foreign substance
- Recall alert: Nearly 1M bottles of kidney, heart medications recalled
- Lupin Pharmaceuticals is recalling 2.5 million bottles of prescription steroid eye drops over contamination
- Nearly 1 million bottles of medication used to treat heart failure recalled nationwide